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DISCLAIMER
The use of company or product name(s) is for identification only and does not imply endorsement by
the Agency for Toxic Substances and Disease Registry.
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UPDATE STATEMENT
Toxicological profiles are revised and republished as necessary, but no less than once every three
years. For information regarding the update status of previously released profiles, contact ATSDR at:
Agency for Toxic Substances and Disease Registry
Division of Toxicology/Toxicology Information Branch
1600 Clifton Road NE, E-29
Atlanta, Georgia 30333
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THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS:
1. Green Border Review. Green Border review assures consistency with ATSDR policy.
2. Health Effects Review. The Health Effects Review Committee examines the health effects
chapter of each profile for consistency and accuracy in interpreting health effects and
classifying end points.
3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to
substance-specific minimal risk levels (MRLs), reviews the health effects database of each
profile, and makes recommendations for derivation of MRLs.
4. Quality Assurance Review. The Quality Assurance Branch assures that consistency across
profiles is maintained, identifies any significant problems in format or content, and establishes
that Guidance has been followed.
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PEER REVIEW
A peer review panel was assembled for tetryl. The panel consisted of the following members:
1. Dr. Tim Borges, Technical Information Analyst, Oak Ridge National Laboratories, Oak Ridge,
Tennessee;
2. Dr. Lawrence Holland, Private Consultant, Los Alamos, New Mexico; and
3. Dr. Theodore Mill, SRI International, Menlo Park, California.
These experts collectively have knowledge of tetryl’s physical and chemical properties, toxicokinetics,
key health end points, mechanisms of action, human and animal exposure, and quantification of risk to
humans. All reviewers were selected in conformity with the conditions for peer review specified in
Section 104(i)(13) of the Comprehensive Environmental Response, Compensation, and Liability Act,
as amended.
Scientists from the Agency for Toxic Substances and Disease Registry (ATSDR) have reviewed the
peer reviewers’ comments and determined which comments will be included in the profile. A listing
of the peer reviewers’ comments not incorporated in the profile, with a brief explanation of the
rationale for their exclusion, exists as part of the administrative record for this compound. A list of
databases reviewed and a list of unpublished documents cited are also included in the administrative
record.
The citation of the peer review panel should not be understood to imply its approval of the profile’s
final content. The responsibility for the content of this profile lies with the ATSDR.









